In line with the global action plan to combat antimicrobial resistance adopted by the WHO in 2015 and the publication in November 2016 of the interministerial roadmap for controlling antibiotic resistance in France, the Government, through the General Secretariat for Investment, has decided to set up a priority research programme (PPR) on antimicrobial resistance with a budget of €40 million over ten years as part of the third investment programme for the future (PIA3), which is part of the France 2030 plan.
The PPR Antibiotics Resistance programme has funded multiple research projects. In 2020, the first call for projects, ‘Understand, Innovate, Act’, was launched with a budget of €25 million. This call supported 11 ambitious, structuring projects that promote interdisciplinarity as part of a One Health approach.
In 2026, the PPR Antibiorésistance will launch a second call for projects entitled ‘Understand, innovate, act’. It aims to fund consortia proposing four-year projects worth between €600k and €750k focusing on four major challenges:
- Dynamics and control of the emergence, transmission and spread of antibiotic resistance.
- Optimisation of antibiotic use in human and veterinary medicine.
- Individual, ethnological, sociological, economic, political and cultural determinants of antibiotic resistance.
- Therapeutic innovation.
The deadline for submitting projects is 14 April 2026 (11:00 CET).